• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Severe 2009 H1N1 influenza in pregnant women in Spain

tetano

Editor, Senior Moderator
Crit Care Med. 2011 Jan 21. [Epub ahead of print]
Severe 2009 H1N1 influenza in pregnant women in Spain.

Marav?-Poma E, Martin-Loeches I, Regidor E, Laplaza C, Cambra K, Aldunate S, Guerrero JE, Loza-Vazquez A, Arnau E, Almirall J, Lorente L, Arenzana A, Magret M, Reig Valero R, Marquez E, Gonzalez N, Bermejo-Martin JF, Rello J; Grupo Espa?ol de Trabajo de Gripe Grave A (SEMICYUC).

From the Intensive Care Unit (EMP, CL, SA), Hospital Virgen del Camino, Pamplona; Critical Care Department (IML), Joan XXIII University Hospital, University Rovira i Virgili, CIBER Enfermedades Respiratorias (CIBERes) Tarragona; Unidad de Metodolog?a (KC), Fundaci?n Miguel Servet, Pamplona; Hospital Gregorio Mara??n (JEG), Madrid; Hospital Universitario de Valme (ALV), Sevilla; Hospital Universitario Vall d'Hebron (EA, JR), VHIR-UAB, CIBERES, Barcelona; Hospital de Matar? (JA), Matar?; CIBERES (LL), Barcelona Universitario de Canarias, Tenerife; Hospital Virgen de la Macarena (AA), Sevilla; Hospital Sant Joan de Reus (MM), Reus; Hospital General de Castell?n (RRV), Valencia; Hospital Infanta Elena (EM), Huelva; Hospital Donostia (NG), San Sebastian; and Infection and Immunity Unit (JFBM), Hospital Cl?nico Universitario-IECSCYL, Valladolid, Spain.
Abstract

OBJECTIVES: To describe the severity of the 2009 influenza H1N1v illness among pregnant women admitted to Spanish intensive care units.

DESIGN AND PATIENTS: Prospective, observational, multicenter study conducted in 148 Spanish intensive care units. We reviewed demographic and clinical data from the Spanish Society of Intensive Care Medicine database reported from April 23, 2009, to February 15, 2010. We included women of reproductive age (15-44 yrs) with confirmed H1N1v infection admitted to intensive care units.

MAIN RESULTS: Two hundred thirty-four women of reproductive age were admitted to intensive care units, 50 (21.4%) of them pregnant. Seven deaths were recorded in pregnant and 22 in nonpregnant women. Among intensive care unit admissions, there were no statistically significant differences between pregnant women and nonpregnant in Acute Physiology and Chronic Health Evaluation II, Sequential Organ Failure Assessment scores, chest x-rays, inotrope requirement, or need for mechanical ventilation or steroid therapy. Mortality risk was significantly associated with Acute Physiology and Chronic Health Evaluation II, Sequential Organ Failure Assessment, and obesity. Viral pneumonia was more frequent in pregnant women than in nonpregnant women, with an odds ratio (adjusted for asthma, time from onset influenza symptoms to hospital admission and obesity) of 4.9 (95% confidence interval: 1.4-17.2). The development of primary viral pneumonia in women of reproductive age appeared to be related to the time of commencement of antiviral treatment, the lowest rates being reported with initiation of antiviral therapy within 48 hrs of symptom onset (63.6% vs. 82.6%, p = .03). However, antiviral therapy was started within this time span in only 14% of pregnant women.

CONCLUSIONS: More than 20% of women of reproductive age admitted to intensive care unit for pH1N1 infection were pregnant. Pregnancy was significantly associated with primary viral pneumonia. Pregnant women should receive prompt treatment with oseltamivir within 48 hrs of the onset of influenza symptoms.

PMID: 21263317 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/21263317
 
Back
Top Bottom